AZD2858,
AZD2858,
486424-20-8,
AZD-2858,
AZD 2858,
CHEMBL2177161,
3-amino-6-(4-((4-methylpiperazin-1-yl)sulfonyl)phenyl)-N-(pyridin-3-yl)pyrazine-2-carboxamide,
3-amino-6-[4-(4-methylpiperazin-1-yl)sulfonylphenyl]-N-pyridin-3-ylpyrazine-2-carboxamide,
3-Amino-6-{4-[(4-Methylpiperazin-1-Yl)sulfonyl]phenyl}-N-Pyridin-3-Ylpyrazine-2-Carboxamide,
GSK-3 inhibition,
3-amino-6-{4-[(4-methylpiperazin-1-yl)sulfonyl]phenyl}-N-(pyridin-3-yl)pyrazine-2-carboxamide,
GTPL8478,
SCHEMBL3327702,
C21H23N7O3S,
AOB6850,
EX-A707,
FHCSBLWRGCOVPT-UHFFFAOYSA-N,
HMS3653E04,
BCP08089,
KS-00000SR4,
2237AH,
BDBM50397745,
MFCD26397072,
s7253,
ZINC34299752,
AKOS026750282,
CS-1672,
SB19272,
compound 18 [PMID: 22489897],
NCGC00386288-05,
4CA-0226,
AC-30277,
AK317380,
BC600311,
HY-15761,
QC-11722,
FT-0700316,
SW219701-1,
J-690306,
3-Amino-6-[4-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]-N-3-pyridinyl-pyrazinecarboxamide,
2-(4-Fluoro-phenyl)-6-methyl-4-(3-trifluoromethyl-phenyl)-1,6-dihydro-2H-1,2,5,6,7-pentaaza-as-indacen-3-one,
GR9,
D04WZK,
ACN-025759,
CID10138980,
B1537,
A13060,
3-amino-6-[4-(4-methylpiperazin-1-yl)sulfonylphenyl]-N-pyridin-3-yl-pyrazine-2-carboxamide,
2-Pyrazinecarboxamide, 3-amino-6-[4-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]-N-3-pyridinyl-,
3-amino-6-(4-(4-methylpiperazin-1-ylsulfonyl)phenyl)-N-(pyridin-3-yl)pyrazine-2-carboxamide,
N/A,